PEPTIDE PRESS
PEPTIDES · LONGEVITY · PERFORMANCE · HUMAN POTENTIAL
Tag

Tesamorelin

2 articles


Performance · analysis
How the community is researching tesamorelin

Tesamorelin is unusual: an FDA-approved drug with a defined regimen and real trial data, used by the community for a different, off-label goal. Comparing the label with the practice is where this one gets interesting.

PERFORMANCE · JULY 18, 2026 · 6 MIN READ · 3 SOURCES
The Peptide Press Briefing

A weekly digest of peptide research, longevity, performance, and the science shaping human potential.